Drug Profile
RO 600946
Latest Information Update: 08 Nov 2006
Price :
$50
*
At a glance
- Originator Roche
- Class Antidepressants; Anxiolytics; Small molecules
- Mechanism of Action Serotonin 2C receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 08 Nov 2006 Discontinued - Preclinical for Anxiety disorders in Switzerland (unspecified route)
- 08 Nov 2006 Discontinued - Preclinical for Depression in Switzerland (unspecified route)
- 07 Sep 1998 New profile